Wolf Gunter, Jocks Thomas, Zahner Gunther, Panzer Ulf, Stahl Rolf A K
Division of Nephrology, Department of Medicine, University of Hamburg, 20246 Hamburg, Germany.
Am J Physiol Renal Physiol. 2002 Nov;283(5):F1075-84. doi: 10.1152/ajprenal.00349.2001.
Glomerular upregulation of monocyte chemotactic protein-1 (MCP-1), followed by an influx of monocytes resulting eventually in extracellular matrix deposition is a common sequel of many types of glomerulonephritis. However, it is not entirely clear how early expression of MCP-1 is linked to the later development of glomerulosclerosis. Because transforming growth factor-beta (TGF-beta) is a key regulator of extracellular matrix proteins, we hypothesized that there might be a regulatory loop between early glomerular MCP-1 induction and subsequent TGF-beta expression. To avoid interference with other cytokines that may be released from infiltrating monocytes, isolated rat kidneys were perfused with a polyclonal anti-thymocyte-1 antiserum (ATS) and rat serum (RS) as a complement source to induce glomerular injury. Renal TGF-beta protein and mRNA expressions were strongly stimulated after perfusion with ATS-RS. This effect was attenuated by coperfusion with a neutralizing anti-MCP-1 but was partly mimicked by perfusion with recombinant MCP-1 protein. On the other hand, renal MCP-1 expression and production were stimulated by administration of ATS-RS. Additional perfusion with an anti-TGF-beta antibody further aggravated this increase, whereas application of recombinant TGF-beta protein reduced MCP-1 formation. Our data demonstrate an intrinsic regulatory loop in which increased MCP-1 levels stimulate TGF-beta formation in resident glomerular cells in the absence of infiltrating immune competent cells.
单核细胞趋化蛋白-1(MCP-1)在肾小球中的上调,随后单核细胞的流入最终导致细胞外基质沉积,是多种类型肾小球肾炎的常见后果。然而,MCP-1的早期表达如何与肾小球硬化的后期发展相关联尚不完全清楚。由于转化生长因子-β(TGF-β)是细胞外基质蛋白的关键调节因子,我们推测在肾小球MCP-1的早期诱导与随后的TGF-β表达之间可能存在一个调节环。为避免干扰可能从浸润单核细胞释放的其他细胞因子,用多克隆抗胸腺细胞-1抗血清(ATS)和大鼠血清(RS)作为补体来源灌注分离的大鼠肾脏,以诱导肾小球损伤。用ATS-RS灌注后,肾脏TGF-β蛋白和mRNA表达受到强烈刺激。这种作用被与中和抗MCP-1共同灌注所减弱,但部分被重组MCP-1蛋白灌注所模拟。另一方面,给予ATS-RS刺激肾脏MCP-1的表达和产生。用抗TGF-β抗体进一步灌注会加剧这种增加,而应用重组TGF-β蛋白则会减少MCP-1的形成。我们的数据证明了一个内在调节环,即在没有浸润免疫活性细胞的情况下,升高的MCP-1水平会刺激驻留肾小球细胞中TGF-β的形成。